Insider filing · NBIX
David W. Boyer
Chief Corp. Affairs Officer
profile →
Neurocrine Biosciences, Inc.
NBIX · Healthcare · 59 filings in 24 months
ticker →
David W. Boyer sold $609K of Neurocrine Biosciences (NBIX)
Executed May 26, disclosed May 28, 2 days later.
Value, as filed
$609K
3,888 sh × $156.64
Executed
May 26
the trade date, as filed
Disclosed
May 28
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
DBDavid W. Boyer (Chief Corp. Affairs Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $609K of NBIX (3,888 sh × $156.64, as filed), executed May 26.
The name
NBIXHealthcare · Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunolog…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by David W. Boyer in NBIX
NBIXSALE
Neurocrine Biosciences, Inc.
$130K826 sh × $157.45
Exec Sep 14
Filed Sep 15 · 5:03 PM ET NBIXSALE Neurocrine Biosciences, Inc. $112K
955 sh × $116.79
Exec Feb 13 2025
Filed Feb 14 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $169K
1,104 sh × $152.94
Exec Jan 31 2025
Filed Feb 4 2025 · 5:30 PM ET